Yi-Jun Ge

Yi-Jun Ge

Auto-generated profile, based on publicly available information

Yi-Jun Ge

Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Ageing Research Reviews
Verified
Journal Article
Closed access
YGYi-Jun Ge
Yi-Jun Ge
WXWei Xu
Wei Xu
YOYa-Nan Ou
Ya-Nan Ou
YQYi Qu
Yi Qu
YMYa-Hui Ma
Ya-Hui Ma
JYJintai Yu
Jintai Yu

13 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SHShu-Yi Huang
Shu-Yi Huang
YGYi-Jun Ge
Yi-Jun Ge
PRPeng Ren
Peng Ren
BWBang-Sheng Wu
Bang-Sheng Wu
WGWeikang Gong
Weikang Gong
JYJintai Yu
Jintai Yu
Brain glymphatic activity, as indicated by diffusion-tensor imaging analysis along the perivascular space (ALPS) index, is involved in developmental neuropsychiatric and neurodegenerative diseases, but its genetic architecture is poorly understood. Here, we identified 17 unique genome-wide significant loci and 161 candidate genes linked to the ALPS-indexes in a discovery sample of 31,021 individuals from the UK Biobank. Seven loci were replicated in two independent datasets. Genetic signals located at the 2p23.3 locus yielded significantly concordant effects in both young and aging cohorts. Genetic correlation and polygenic overlap analyses indicate a common underlying genetic mechanism between the ALPS-index, ventricular volumes, and cerebrospinal fluid tau levels, with GMNC (3q28) and C16orf95 (16q24.2) as the shared genetic basis. Our findings enhance the understanding of the genetics of the ALPS-index and provide insight for further research into the neurobiological mechanisms of glymphatic clearance activity across the lifespan and its relation to neuropsychiatric phenotypes.

1 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XHXiao-Yu He
Xiao-Yu He
BWBang-Sheng Wu
Bang-Sheng Wu
LYLiu Yang
Liu Yang
YGYu Guo
Yu Guo
YDYue-Ting Deng
Yue-Ting Deng
JYJintai Yu
Jintai Yu
Previous genetic studies of venous thromboembolism (VTE) have been largely limited to common variants, leaving the genetic determinants relatively incomplete. We performed an exome-wide association study of VTE among 14,723 cases and 334,315 controls. Fourteen known and four novel genes (SRSF6, PHPT1, CGN, and MAP3K2) were identified through protein-coding variants, with broad replication in the FinnGen cohort. Most genes we discovered exhibited the potential to predict future VTE events in longitudinal analysis. Notably, we provide evidence for the additive contribution of rare coding variants to known genome-wide polygenic risk in shaping VTE risk. The identified genes were enriched in pathways affecting coagulation and platelet activation, along with liver-specific expression. The pleiotropic effects of these genes indicated the potential involvement of coagulation factors, blood cell traits, liver function, and immunometabolic processes in VTE pathogenesis. In conclusion, our study unveils the valuable contribution of protein-coding variants in VTE etiology and sheds new light on its risk stratification.

19 September 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YQYi-Xuan Qiang
Yi-Xuan Qiang
YWYi-Xuan Wang
Yi-Xuan Wang
XHXiao-Yu He
Xiao-Yu He
YDYue-Ting Deng
Yue-Ting Deng
YGYi-Jun Ge
Yi-Jun Ge
JYJintai Yu
Jintai Yu
Circulating metabolites are crucial to biological processes underlying health and diseases, yet their genetic determinants remain incompletely understood. Here, we investigate the genetic architecture of nuclear magnetic resonance-based metabolomics, analyzing 249 metabolic measures and 64 biologically plausible ratios in 254,825 participants. We conduct a genome-wide association study (GWAS) identifying 24,438 independent variant-metabolite associations across 427 loci, with effect sizes highly concordant with 19 previous studies. Fine-mapping pinpoints 3610 putative causal associations, 785 of which are novel. Additionally, we utilize whole exome sequencing data and uncover 2948 gene-metabolite associations through aggregate testing, underscoring the importance of rare coding variants overlooked in GWAS. Integrating our findings with disease genetics reveals potential causal associations, such as between acetate levels and the risk of atrial fibrillation and flutter. Collectively, this study delineates the complex genetic architecture of the plasma metabolome, offering a valuable resource for future investigations into disease mechanisms and therapeutic strategies.

28 April 2026 in Nature Communications
Verified
Journal Article
Open access
YZYong-Li Zhao
Yong-Li Zhao
DZDan-Dan Zhang
Dan-Dan Zhang
PGPei-Yang Gao
Pei-Yang Gao
YFYan Fu
Yan Fu
YGYi-Jun Ge
Yi-Jun Ge
JYJintai Yu
Jintai Yu
Social isolation and loneliness are increasingly recognized as detrimental risk factors for brain health. Here, utilizing data from 383,421 participants in the UK Biobank, we identify significant associations between social isolation, loneliness, and the incidence of 11 neurological and psychiatric disorders, including major depressive disorder (MDD), schizophrenia, bipolar disorder, anxiety disorders, sleep disorders, dementia, Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis, and epilepsy employing Cox regression models. Furthermore, using Mendelian randomization analysis we find evidence for putative relationships from social isolation and loneliness to MDD, schizophrenia, sleep disorders, and epilepsy. We also observe significant associations between social isolation, loneliness, and worse cognitive and emotional performance, as well as alterations in brain structures. Additionally, mediation analyses indicate that peripheral inflammatory and biochemical markers partially mediated the links from social isolation and loneliness to neurological and psychiatric disorders.

22 June 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYi-Xuan Wang
Yi-Xuan Wang
YQYi-Xuan Qiang
Yi-Xuan Qiang
YGYi-Jun Ge
Yi-Jun Ge
YDYue-Ting Deng
Yue-Ting Deng
BWBang-Sheng Wu
Bang-Sheng Wu
JYJintai Yu
Jintai Yu
Blood metabolites are critical biomarkers linking genetic variation to diverse health outcomes, exhibiting significant variability across individuals. Here, we analyze and integrate whole-genome sequencing with plasma metabolomics to investigate the genetic architecture of 313 metabolic biomarkers in up to 199,138 UK Biobank participants. Through single-variant analyses, we identify 36,105 independent signals, with 22.20% being novel. Furthermore, we pinpoint 12,361 putative causal variant-trait associations, demonstrating enhanced causal signal discovery and improved fine-mapping resolution compared with imputed array-based approaches. Rare-variant aggregate testing reveals 1,527 conditionally independent protein-coding gene-trait pairs, with 32.9% being unique to non-coding regions. We estimate the heritability at a median of h2 = 0.31, nearly tripling the heritability estimates obtained from array-based approaches. Integrating our findings with disease genetics reveals 245 potential causal associations, such as that between omega-3 fatty acids and cholelithiasis risk. Prioritizing proteins with concordant effects on metabolites and clinical outcomes revealed 410 potential targets, offering opportunities for therapeutic strategies and drug repurposing. Our open-access resource (https://metabolome-whole-genome-landscape.com/) provides a foundation for future research into metabolic pathways, disease mechanisms, and therapeutic development.